R, P. and Bashir, S. (2016) “CRITICAL REVIEW OF PHARMACOGENOMICS IN ANTIPARKINSONIAN DRUG THERAPY: IMPACT ON CLINICAL MANAGEMENT OF PARKINSON’S DISEASE”, Asian Journal of Pharmaceutical and Clinical Research, 9(6), pp. 24–27. doi: 10.22159/ajpcr.2016.v9i6.13350.